Target intelligence / Profile preview

Keratinocyte cell turnover enzymes

Molecular classification
Enzyme (non-specific group; includes proteases, transglutaminases, protein kinases, etc.), Other (since this refers to a collection, not a single family)
01

Overview

“Keratinocyte cell turnover enzymes” collectively refers to multiple enzymes involved in the regulation of keratinocyte renewal and differentiation. Key classes include **proteases** (notably, serine proteases like kallikreins, cysteine proteases like cathepsins), **transglutaminases** (especially transglutaminase 1, which crosslinks proteins for cornified envelope formation), and other regulatory enzymes such as certain kinases (for example, various isoforms of protein kinase C implicated in differentiation signaling). These enzymes orchestrate the complex molecular events underlying epidermal turnover: from cell proliferation in the basal layer, through differentiation in the spinous and granular layers, to the programmed cell death and proteolytic degradation that create corneocytes for the outer barrier. Dysregulation can lead to various skin diseases characterized by abnormal cell thickening, scaling, or compromised barrier function. As such, individual members of these enzyme families, but not the entire group as a whole, may be considered therapeutic targets.

Other names
Keratinocyte turnover enzymesEpidermal differentiation enzymesCornification-related enzymesProteases in skin barrier formation
02

Mechanism of action

Modulation of protease activity to regulate desquamation (shedding of corneocytes) Promotion or inhibition of terminal differentiation Alteration of barrier protein cross-linking (e.g., transglutaminases inducing cornified envelope formation)

03

Biological functions

Cell turnover/regenerationTerminal differentiation (cornification)Proteolysis of structural and regulatory proteinsBarrier formation in epidermis
04

Disease associations

Skin disorders (e.g., psoriasis, atopic dermatitis, inherited ichthyoses)InflammationImpaired wound healingCancer (in some cases, dysregulated turnover enzymes are implicated)
05

Safety considerations

Excessive inhibition: impaired desquamation or barrier dysfunction (hyperkeratosis)Over-activation: increased desquamation, barrier loss, skin irritation
06

Interacting drugs

Topical retinoids (indirectly modulate enzymes of differentiation)

3 more in the full profile.

07

Biomarkers

Profilaggrin/filaggrin levelsTransglutaminase 1 activitySerine protease (kallikrein family) expressionCathepsin D levelsCaspase 14 (involved in cornification)

Beyond the preview

Go deeper on Keratinocyte cell turnover enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratinocyte cell turnover enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call